On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...